Prediction of Future Weight Change With Dopamine Transporter

Weight Change, Body Clinical Trial

Official title:

Prediction of Future Weight Change With Dopamine Transporter

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03146429
• Other study ID #: PusanNUH-2017
• Status: Completed
• First received: May 7, 2017
• Last updated: April 22, 2018
• Start date: January 1, 2017
• Est. completion date: April 15, 2017

Study information

• Verified date: April 2018
• Source: Pusan National University Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: April 15, 2017
• Est. primary completion date: April 15, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 30 Years and older

Eligibility

Inclusion Criteria:

• males or females with their age of 30 years or older at screening

Exclusion Criteria:

• subjects with a neurological disorder, a first degree relative with idiopathic PD, Montreal Cognitive Assessment score of 26 or less, medications that might interfere with DAT SPECT scans, anticoagulants that might preclude safe completion of the lumbar puncture, or investigational drugs, and a condition that precludes the safe performance of routine lumbar puncture

Related Conditions & MeSH terms

• Body Weight
• Body Weight Changes
• Weight Change, Body

Intervention

Diagnostic Test:
• I-123 FP-CIT Single photon emission tomography
Brain scan for dopamine transporter

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Pusan National University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Weight change	weight change per year until 5 years after SPECT	1, 2, 3, 4, 5 year after SPECT